Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Results from the ARMYDA-6 MI (antiplatelet therapy for reduction of myocardial damage during angioplasty-myocardial infarction) randomized study

Journal of the American College of Cardiology

Volumn 58, Issue 15, 2011, Pages 1592-1599

  Patti, Giuseppe ^a   Bárczi, György ^b   Orlic, Dejan ^c   Mangiacapra, Fabio ^a,d   Colonna, Giuseppe ^e   Pasceri, Vincenzo ^f   Barbato, Emanuele ^d   Merkely, Béla ^b   Édes, István ^b   Ostojic, Miodrag ^c   Wijns, William ^d   Di Sciascio, Germano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d OLV HOSPITAL   (Belgium)

^e VITO FAZZI HOSPITAL   (Italy)

^f SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

acute myocardial infarction; clopidogrel; infarct size; outcome; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; SARTAN DERIVATIVE; TROPONIN I;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 80053321770     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.06.044     Document Type: Article

References (39)

1. S.R. Steinhubl, P.B. Berger, J.T. Mann 3rd CREDO Investigators Clopidogrel for the Reduction of Events During Observation Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
2. S.R. Mehta, S. Yusuf, R.J. Peters Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
3. M.S. Sabatine, C.P. Cannon, C.M. Gibson CLARITY-TIMI 28 Investigators Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189 (Pubitemid 40397259)
4. M.S. Sabatine, C.P. Cannon, C.M. Gibson Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators Effect of clopidogrel pre-treatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA 294 2005 1224 1232 (Pubitemid 41352110)
5. P.A. Gurbel, K.P. Bliden, B.L. Hiatt, and C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913 (Pubitemid 36736631)
6. G. Patti, A. Nusca, F. Mangiacapra, L. Gatto, A. D'Ambrosio, and G. Di Sciascio Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention Results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of MYocardial Damage During AngioplastyPlatelet Reactivity Predicts Outcome) study J Am Coll Cardiol 52 2008 1128 1133
7. G. Di Sciascio, G. Patti, V. Pasceri, G. Colonna, F. Mangiacapra, A. Montinaro ARMYDA-4 RELOAD Investigators Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial Eur Heart J 31 2010 1337 1343
8. G. Di Sciascio, G. Patti, V. Pasceri, L. Gatto, G. Colonna, A. Montinaro ARMYDA-5 PRELOAD Investigators Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial J Am Coll Cardiol 56 2010 550 557
9. G. Patti, G. Colonna, V. Pasceri, L.L. Pepe, A. Montinaro, and G. Di Sciascio Randomized trial of high loading dose of clopidogrel for reduction of peri-procedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study Circulation 111 2005 2099 2106 (Pubitemid 40577905)
10. T. Cuisset, C. Frere, and J. Quilici Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting J Am Coll Cardiol 48 2006 1339 1345 (Pubitemid 44436814)
11. J.H. Jung, P.K. Min, and S.H. Lee Clopidogrel pretreatment before primary percutaneous coronary stenting in patients with acute ST-segment elevation myocardial infarction: comparison of high loading dose (600 mg) versus low loading dose (300 mg) Coron Artery Dis 20 2009 150 154
12. F. Mangiacapra, O. Muller, and A. Ntalianis Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty Am J Cardiol 106 2010 1208 1211
13. G. Dangas, R. Mehran, G. Guagliumi HORIZONS-AMI Trial Investigators Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 54 2009 1438 1446
14. C.U. Choi, S.W. Rha, and D.J. Oh Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry Am Heart J 161 2011 373 382
15. T. Svilaas, P.J. Vlaar, and I.C. van der Horst Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567 (Pubitemid 351214283)
16. R.T. Vollmer, R.H. Christenson, K. Reimer, and E.M. Ohman Temporal creatine kinase curves in acute myocardial infarction: implications of a good empiric fit with the log-normal function Am J Clin Pathol 100 1993 293 298 (Pubitemid 23268655)
17. The TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial N Engl J Med 312 1985 932 936
18. S.J. Brener, L.A. Barr, J.E. Burchenal ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) investigators Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction Circulation 98 1998 734 741 (Pubitemid 28391837)
19. A.K. Rao, C. Pratt, and A. Berke Thrombolysis in Myocardial Infarction (TIMI) trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11 (Pubitemid 18029027)
20. F. Fernández-Avilés, J.J. Alonso, G. Pea GRACIA-2 (Groupo de Análisis de Cardiopatía Isquémica Aguda) Investigators Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial Eur Heart J 28 2007 949 960 (Pubitemid 47343896)
21. L. Mauri, W. Hsieh, J.M. Massaro, K.K.L. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029 (Pubitemid 46376802)
22. G. Campo, M. Valgimigli, and D. Gemmati Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY study J Am Coll Cardiol 48 2006 2178 2185 (Pubitemid 44873056)
23. N.M. Ernst, H. Suryapranata, and K. Miedema Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction J Am Coll Cardiol 44 2004 1187 1193 (Pubitemid 39208872)
24. M. Frossard, I. Fuchs, and J.M. Leitner Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 110 2004 1392 1397 (Pubitemid 39238016)
25. N.G. Uren, T. Crake, D.C. Lefroy, R. DeSilva, G.J. Davies, and A. Maseri Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction N Engl J Med 331 1994 222 227 (Pubitemid 24226679)
26. M. Gawaz, F.J. Neumann, I. Ott, A. Schiessler, and A. Schomig Platelet function in acute myocardial infarction treated with direct angioplasty Circulation 93 1996 229 237 (Pubitemid 26031479)
27. S. Matetzky, B. Shenkman, and V. Guetta Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
28. G. Montalescot, S.D. Wiviott, E. Braunwald TRITON-TIMI 38 Investigators Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
29. S.D. Wiviott, E. Braunwald, C.H. McCabe TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
30. C.P. Cannon, R.A. Harrington, S. James PLATelet inhibition and patient Outcomes (PLATO) Investigators Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Lancet 375 2010 283 293
31. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)
32. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697 (Pubitemid 351221218)
33. V. Pasceri, G. Patti, and G. Di Sciascio Prasugrel versus clopidogrel N Engl J Med 358 2008 1298 1299
34. I. Muller, M. Seyfarth, and S. Rudiger Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement Heart 85 2001 92 93 (Pubitemid 32973418)
35. M.E. Leimbach, V. Peyrou, U.M. Marzec, N.A.F. Chronos, S.B. King, and L.A. Harker Single-dose clopidogrel inhibition of platelet adenosine receptor function in patients with atherosclerotic coronary artery disease Circulation 100 Suppl I 1999 I681
36. P.A. Gurbel, K.P. Bliden, K.M. Hayes, J.A. Yoho, W.R. Herzog, and U.S. Tantry The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting J Am Coll Cardiol 45 2005 1392 1396 (Pubitemid 40615608)
37. S.R. Mehta, J.F. Tanguay, J.W. Eikelboom CURRENT-OASIS 7 Trial Investigators Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
38. G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, and G. Di Sciascio High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation Results of the ARMYDA-150 mg randomized study J Am Coll Cardiol 57 2011 771 778
39. W. Wijns, P. Kolh, N. Danchin European Association for Percutaneous Cardiovascular Interventions Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555